None listed
Conditions
Interventions
Sponsors
Kao Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese males and females aged 20 to 59 years old at the time of informed consent. 2. Those who have subjective symptoms of red, itchy and dry skin. 3. Those who have subjective allergy-related symptoms. 4. Those who with at least one allergen-specific IgE antibody level of 0.35 UA/mL or higher.
Exclusion criteria
Exclusion criteria: 1. Those who currently attend a clinic for treatment of skin diseases and allergic diseases. 2. Those who are|were undergoing allergen immunotherapy (sublingual immunotherapy) to cedar pollen allergen and|or mites allergen, at present or over the past 2 years. 3. Those who is presence of metabolic disease, abnormalities of gastrointestinal, circulatory or hematological, viral infection. 4. Those who have been infected with viruses of hepatitis B or C, syphilis or HIV. 5. Those who have had allergic attack (anaphylactic shock or other breathing difficulties) due to an allergic disease in the past. 6. Those who have a history of inpatient treatment for allergic diseases in the past previous hospitalization. 7. Those who have experienced allergic symptoms due to the intake of certain foods. 8. Those who use drugs which are considered to influence the outcome on a regular basis. 9. Those who regularly take certain supplements or have plan to take them during the trial period. 10. Those who have excessive sunburn or scraped skin on the test sites, or have a beard. 11. Those who have experienced cosmetic operation or are going to go to beauty salon during the test period. 12. Those whose BMI is less than 18.5, or over 30. 13. Heavy drinkers. 14. Smokers 15. Those who are currently pregnant or breastfeeding, or wish to become pregnant during the trial period. 16. Those who plan to have a long business trip or travel. 17. Shift workers. 18. Outdoor workers. 19. Those who plan to participate in the other clinical trial during the trial period. 20. Those who are judged appropriate by the study director or person in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin image analysis of redness | — |
Secondary
| Measure | Time frame |
|---|---|
| -Transepidermal water loss -Skin capacitance and conductance -Skin image analysis -Blood analysis -Stratum corneum analysis -Questionnaire | — |
Countries
Japan
Contacts
Public ContactTomoko Yasu
Kao Corporation Human Health Care Products Research Lab.
Outcome results
None listed